We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




New Catheter-Delivered Embolic Shows Promise for Treating Brain Bleed

By HospiMedica International staff writers
Posted on 12 Jan 2023
Print article
Image: Image showing the distal filling of the IMPASS Embolic Device (Photo courtesy of Fluidx Medical)
Image: Image showing the distal filling of the IMPASS Embolic Device (Photo courtesy of Fluidx Medical)

Chronic subdural hematomas (CSDH) occurring on the surface of the brain is a common pathology that can result in death and/or disability in patients. CSDH is usually treated by drilling a hole in the skull and draining the blood. However, minimally invasive catheter-based middle meningeal artery (MMA) embolization holds great promise in addressing CSDH and is particularly suitable for elderly patients as well as those who are unable to undergo invasive surgical procedures. In this procedure, the surgeon navigates a small catheter into the MMA located within the dura mater which covers the brain, after which an embolic material is delivered into the vessel in order to block arterial flow.

In-vivo research by Fluidx Medical Technology (Salt Lake City, UT, USA) has shown that its IMPASS Embolic Device is successful in MMA embolizations which can be used to treat CSDH on the surface of the brain. The IMPASS Embolic Device uses core Fluidx embolic technology but is designed particularly for neurovascular uses. The material is a low viscosity, aqueous-based solution that solidifies into a durable embolus upon delivery without polymerization or dimethyl-sulfoxide (DMSO) precipitation.

The Fluidx embolic platform is anticipated to bring simple preparation and controllable material delivery to a variety of applications. The IMPASS device is packaged in a ready-to-use syringe, can be prepped tableside by the clinician in 30 seconds, and delivered through standard microcatheters without the need for complex mixing systems or special delivery catheters.

"We've been listening to clinicians and they need better tools to treat CSDH," said Danny Smith, VP of R&D for Fluidx. "We designed the IMPASS Embolization Device to work with standard embolization catheters and embolize small microvasculature in the MMA. Our results are encouraging and the IMPASS product could be a great solution to unmet patient needs."

Related Links:
Fluidx Medical Technology

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Neonatal Transport Ventilator
Babylite

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.